此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer

Effect of Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer : A Single Arm Trial

Conventional laparoscopic surgery (CLS) for colorectal cancer has been demonstrated to be safe and feasible and present minimally invasive benefits including faster recovery, reduced postoperative pain and shorter hospital stay, also acquiring comparable oncologic outcomes with open surgery. To achieve further minimally invasive outcomes, SILS plus one port surgery was attempted by some surgeons. Preliminary results showed that SILS+1 could achieve better minimally invasive benefits than CLS while preserving oncologic feasibility.

Till now, ERAS has been practiced in colorectal cancer surgery for approximately 20 years. Studies have proven that ERAS is safe and significantly improved the recovery course of patients during perioperative period, meanwhile, the expense could be greatly reduced.

Based on ERAS studies protocols and SILS+1 trials, investigators tried to combine SILS+1 with ERAS, hopefully to provide patients with more safe, economic, feasible and rapid surgery and perioperative strategies.

研究概览

研究类型

介入性

注册 (预期的)

120

阶段

  • 阶段2

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Primary tumor diagnosed as adenocarcinoma confirmed pathologically by endoscopic biopsy
  • cT1-4a, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition
  • Located in the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, the upper segment of the rectum.
  • Diameter ≦ 5cm
  • No severe organ dysfunction
  • Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale
  • ASA (American Society of Anesthesiology) score class I or II
  • Written informed consent

Exclusion Criteria:

  • Unsuitable for patients undergoing single incision plus one port laparoscopic surgery
  • Patients with Complications caused by colorectal cancer ( bleeding , perforation, obstruction or incomplete obstruction )
  • Previous abdominal surgery
  • Malignant diseases within the past 5years
  • Requirements of simultaneous surgery for another diseases

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:SILS plus one assistant ERAS

Preoperative:

preadmission information, education, counseling, optimization ( breathing training), shortening fasting time and carbohydrate load

Intraoperative:

The intravenous fluid therapy is restricted. All patients undergo single incision plus one port laparoscopic surgery(SILS plus one).

A suitable warming device (such as forced-air heating blankets) and warmed intravenous fluids are been adopted routinely to keep body temperature

Postoperative:

multimodal analgesia (surgical site infiltration, a nonsteroidal anti-inflammatory drug, epidural analgesia) early oral intake and move. nasogastric tubes should not be used routinely. Nasogastric tubes inserted during surgery are been removed before reversal of an aesthesia.

SILS plus one port surgery and enhanced recovery after surgery protocol both are methods taking the minimally invasive benefits for the patients including faster recovery, reduced postoperative pain and shorter hospital stay.
其他名称:
  • The program of enhanced recovery After Surgery

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Postoperative hospital stays
大体时间:1 month
Days from surgery to discharge
1 month
Rehabilitative rate
大体时间:4 days
The percentage of patients who met discharge criteria in the fourth day after surgery
4 days

次要结果测量

结果测量
措施说明
大体时间
Medical cost
大体时间:1 month
The patient's expenses from surgery to discharge are recorded in RMB "yuan"
1 month
Postoperative pain score
大体时间:Once a day from 6 hours to the fourth day after surgery
Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day . On a scale of 1 to 10, the higher the score, the greater the pain.
Once a day from 6 hours to the fourth day after surgery
Postoperative recovery index
大体时间:1 month
The first Time to early mobilization(hour), flatus(hour), liquid diet(hour), soft diet(hour), removal of the Nasogastric tubes(hour) , removal of the peritoneal drainage(hour) are used to assess the postoperative recovery
1 month
Postoperative inflammatory immune response
大体时间:3 days
It includes the number of white blood cells and lymphocytes,CRP, IL-6
3 days
compliance with ERAS measures
大体时间:perioperative
It is defined as if the patients complete every ERAS measure or not. We can defined it "yes " or "not".
perioperative
6 min postoperative walking test(6MWT)
大体时间:Once a day from the frist to the fourth day after surgery
Study site, subject preparation, trial procedures, and medical monitoring refer to the 6MWT guidelines issued by the American thoracic society in 2002.
Once a day from the frist to the fourth day after surgery
hospital readmissions
大体时间:30days
It can be defined as the number of patients readmitted within 30 days because of postoperative complications.
30days
Morbidity and mortality rates
大体时间:30 days
Morbidity and mortality rates are defined as postoperative complications graded according to Clavien-Dindo within 30 days.
30 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Wang Yannan, M.D、Nanfang Hospital of Southern Medical University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (预期的)

2020年2月15日

初级完成 (预期的)

2022年2月15日

研究完成 (预期的)

2022年2月15日

研究注册日期

首次提交

2019年12月25日

首先提交符合 QC 标准的

2020年2月12日

首次发布 (实际的)

2020年2月13日

研究记录更新

最后更新发布 (实际的)

2020年2月13日

上次提交的符合 QC 标准的更新

2020年2月12日

最后验证

2019年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅